Brief: Revive Therapeutics expands into cannabinoid-based therapies for liver diseases
16/02/2017 12:08
Feb 16 (Reuters) - Revive Therapeutics Ltd RVV.V -
* Revive Therapeutics announces expansion into
cannabinoid-based therapies targeting liver diseases
Source text for Eikon: ID:nCCN30Hvjx
Further company coverage: RVV.V
((bangalore.newsroom@thomsonreuters.com;))
Recent news on Revive Therapeutics
See all newsBrief: Revive Therapeutics Provides Update Of Key Nerve Agent Countermeasure Study
Brief: Revive Therapeutics Provides Update Of Key Nerve Agent Countermeasure Study
Brief: Revive Therapeutics Announces Closing Of Second Tranche Of Private Placement
Brief: Revive Therapeutics Nears Completion Of Key Nerve Agent Countermeasure Study With Canadian Department Of National Defence
Brief: Revive Therapeutics Provides Update On Research Study Evaluating Bucillamine For Nerve Agent Exposure